Table 3.

Trial registration data

Data category	Information
Primary registry and trial identifying number	Australia New Zealand Clinical Trials Registry ACTRN12617001292369
Date of registration in primary registry	07/09/2017
Secondary identifying numbers	Universal Trial Number U1111-1196-6323
Sources of monetary or material support	Sponsors (below)
Primary sponsor	National Health and Medical Research Council - Research Committee Secretariat NHMRC GPO Box 1421 Canberra ACT 2601
Secondary sponsor	Medibank Health Research Fund - 720 Bourke Street, Docklands, VIC 3008
Contact for public queries	PH (p.hodges@uq.edu.au)
Contact for scientific queries	PH (p.hodges@uq.edu.au)
Public title	Efficacy of a multi-faceted web-based resource on spinal health literacy in patients with low back pain - a randomised controlled trial
Scientific title	Efficacy of a multi-faceted web-based resource on spinal health literacy in patients with low back pain - a randomised controlled trial
Countries of recruitment	Australia
Health condition or problem studied	Low back pain
Intervention	Multi-faceted web-based resource ‘MyBackPain’
Key inclusion and exclusion criteria	Inclusion criteria: >18 years of age, current low back pain, reside in Australia, adequate English to complete surveys, internet access for the duration of the trial
	Exclusion criteria: previous or existing spinal pathology (eg, fracture, cancer, infection, nerve root compromise)
Study type	Randomised controlled trial, participant and assessor blinding, central computerised randomisation
Date of first enrolment	06/12/2017
Target sample size	440 (at least 25% acute participants that is, pain <6 weeks with a minimum of 1 month without symptoms)
Recruitment status	Recruiting
Primary outcome(s)	Health Literacy Questionnaire
Key secondary outcomes	Quality of treatment preference (observed) Patient decision-making—measured by evaluation of observed treatment choices. Treatments used by the participant during the follow-up period will be scored against the recommendations provided in the MyBackPain website, and based on a 5-point rating: ‘strong evidence’, ‘some evidence’, ‘unclear evidence/untested’, ‘evidence of no effect’ and ‘harmful’. The average score will be used.